ホルモンパッチのグローバル市場予測2023-2029

◆英語タイトル:Global Hormone Patch Market Growth 2023-2029

LP Informationが発行した調査報告書(LP23OT8954)◆商品コード:LP23OT8954
◆発行会社(リサーチ会社):LP Information
◆発行日:2023年10月
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「ホルモンパッチのグローバル市場」は、過去の販売実績から2022年の世界のホルモンパッチの総販売量を検討し、2023年から2029年の予測されるホルモンパッチの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のホルモンパッチの市場規模を掲載し、XXX百万米ドル規模の世界のホルモンパッチ市場の詳細な分析を提供します。本インサイトレポートは、世界のホルモンパッチ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のホルモンパッチ市場における各社の独自のポジションをより深く理解するために、ホルモンパッチ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のホルモンパッチ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ホルモンパッチの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。ホルモンパッチの中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ホルモンパッチのヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ホルモンパッチの世界主要メーカーとしては、Mylan Pharmaceuticals Inc.(Viatris)、 Twirla、 Novartis(HEXAL AG)、 Bayer Healthcare Pharmaceuticals、 Noven、 AbbVie、 Hisamitsu Pharmaceutical Co., Inc.、 Watson Pharmaceuticals、 Johnson & Johnson、 ANI Pharmaceuticals、 Zhejiang Yatai Pharmaceutical Company Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のホルモンパッチ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査ではホルモンパッチ市場をセグメンテーションし、種類別 (避妊パッチ、エストラジオールパッチ、その他)、用途別 (病院、診療所)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:避妊パッチ、エストラジオールパッチ、その他

・用途別区分:病院、診療所

・地域別区分
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のホルモンパッチ市場の10年間の市場状況・展望は?
・世界および地域別に見たホルモンパッチ市場成長の要因は何か?
・ホルモンパッチの市場機会はエンドマーケットの規模によってどのように変化するのか?
・ホルモンパッチのタイプ別、用途別の内訳は?
・新型コロナウイルスとロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:ホルモンパッチの年間販売量2018-2029、地域別現状・将来分析
・ホルモンパッチの種類別セグメント:避妊パッチ、エストラジオールパッチ、その他
・ホルモンパッチの種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・ホルモンパッチの用途別セグメント:病院、診療所
・ホルモンパッチの用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のホルモンパッチ市場
・企業別のグローバルホルモンパッチ市場データ:2018-2023年の年間販売量、市場シェア
・企業別のホルモンパッチの年間売上:2018-2023年の売上、市場シェア
・企業別のホルモンパッチ販売価格
・主要企業のホルモンパッチ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ホルモンパッチの地域別レビュー
・地域別のホルモンパッチ市場規模2018-2023:年間販売量、売上
・主要国別のホルモンパッチ市場規模2018-2023:年間販売量、売上
・南北アメリカのホルモンパッチ販売の成長
・アジア太平洋のホルモンパッチ販売の成長
・ヨーロッパのホルモンパッチ販売の成長
・中東・アフリカのホルモンパッチ販売の成長

南北アメリカ市場
・南北アメリカの国別のホルモンパッチ販売量、売上(2018-2023)
・南北アメリカのホルモンパッチの種類別販売量
・南北アメリカのホルモンパッチの用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のホルモンパッチ販売量、売上(2018-2023)
・アジア太平洋のホルモンパッチの種類別販売量
・アジア太平洋のホルモンパッチの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のホルモンパッチ販売量、売上(2018-2023)
・ヨーロッパのホルモンパッチの種類別販売量
・ヨーロッパのホルモンパッチの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のホルモンパッチ販売量、売上(2018-2023)
・中東・アフリカのホルモンパッチの種類別販売量
・中東・アフリカのホルモンパッチの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ホルモンパッチの製造コスト構造分析
・ホルモンパッチの製造プロセス分析
・ホルモンパッチの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・ホルモンパッチの主要なグローバル販売業者
・ホルモンパッチの主要なグローバル顧客

地域別のホルモンパッチ市場予測レビュー
・地域別のホルモンパッチ市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ホルモンパッチの種類別市場規模予測
・ホルモンパッチの用途別市場規模予測

主要企業分析
Mylan Pharmaceuticals Inc.(Viatris)、 Twirla、 Novartis(HEXAL AG)、 Bayer Healthcare Pharmaceuticals、 Noven、 AbbVie、 Hisamitsu Pharmaceutical Co., Inc.、 Watson Pharmaceuticals、 Johnson & Johnson、 ANI Pharmaceuticals、 Zhejiang Yatai Pharmaceutical Company Ltd.
・企業情報
・ホルモンパッチ製品
・ホルモンパッチ販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hormone Patch Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hormone Patch by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hormone Patch by Country/Region, 2018, 2022 & 2029
2.2 Hormone Patch Segment by Type
2.2.1 Contraceptive Patch
2.2.2 Estradiol Patch
2.2.3 Others
2.3 Hormone Patch Sales by Type
2.3.1 Global Hormone Patch Sales Market Share by Type (2018-2023)
2.3.2 Global Hormone Patch Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hormone Patch Sale Price by Type (2018-2023)
2.4 Hormone Patch Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Hormone Patch Sales by Application
2.5.1 Global Hormone Patch Sale Market Share by Application (2018-2023)
2.5.2 Global Hormone Patch Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hormone Patch Sale Price by Application (2018-2023)
3 Global Hormone Patch by Company
3.1 Global Hormone Patch Breakdown Data by Company
3.1.1 Global Hormone Patch Annual Sales by Company (2018-2023)
3.1.2 Global Hormone Patch Sales Market Share by Company (2018-2023)
3.2 Global Hormone Patch Annual Revenue by Company (2018-2023)
3.2.1 Global Hormone Patch Revenue by Company (2018-2023)
3.2.2 Global Hormone Patch Revenue Market Share by Company (2018-2023)
3.3 Global Hormone Patch Sale Price by Company
3.4 Key Manufacturers Hormone Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hormone Patch Product Location Distribution
3.4.2 Players Hormone Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hormone Patch by Geographic Region
4.1 World Historic Hormone Patch Market Size by Geographic Region (2018-2023)
4.1.1 Global Hormone Patch Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hormone Patch Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hormone Patch Market Size by Country/Region (2018-2023)
4.2.1 Global Hormone Patch Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hormone Patch Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hormone Patch Sales Growth
4.4 APAC Hormone Patch Sales Growth
4.5 Europe Hormone Patch Sales Growth
4.6 Middle East & Africa Hormone Patch Sales Growth
5 Americas
5.1 Americas Hormone Patch Sales by Country
5.1.1 Americas Hormone Patch Sales by Country (2018-2023)
5.1.2 Americas Hormone Patch Revenue by Country (2018-2023)
5.2 Americas Hormone Patch Sales by Type
5.3 Americas Hormone Patch Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hormone Patch Sales by Region
6.1.1 APAC Hormone Patch Sales by Region (2018-2023)
6.1.2 APAC Hormone Patch Revenue by Region (2018-2023)
6.2 APAC Hormone Patch Sales by Type
6.3 APAC Hormone Patch Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hormone Patch by Country
7.1.1 Europe Hormone Patch Sales by Country (2018-2023)
7.1.2 Europe Hormone Patch Revenue by Country (2018-2023)
7.2 Europe Hormone Patch Sales by Type
7.3 Europe Hormone Patch Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hormone Patch by Country
8.1.1 Middle East & Africa Hormone Patch Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hormone Patch Revenue by Country (2018-2023)
8.2 Middle East & Africa Hormone Patch Sales by Type
8.3 Middle East & Africa Hormone Patch Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hormone Patch
10.3 Manufacturing Process Analysis of Hormone Patch
10.4 Industry Chain Structure of Hormone Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hormone Patch Distributors
11.3 Hormone Patch Customer
12 World Forecast Review for Hormone Patch by Geographic Region
12.1 Global Hormone Patch Market Size Forecast by Region
12.1.1 Global Hormone Patch Forecast by Region (2024-2029)
12.1.2 Global Hormone Patch Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hormone Patch Forecast by Type
12.7 Global Hormone Patch Forecast by Application
13 Key Players Analysis
13.1 Mylan Pharmaceuticals Inc.(Viatris)
13.1.1 Mylan Pharmaceuticals Inc.(Viatris) Company Information
13.1.2 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product Portfolios and Specifications
13.1.3 Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Mylan Pharmaceuticals Inc.(Viatris) Main Business Overview
13.1.5 Mylan Pharmaceuticals Inc.(Viatris) Latest Developments
13.2 Twirla
13.2.1 Twirla Company Information
13.2.2 Twirla Hormone Patch Product Portfolios and Specifications
13.2.3 Twirla Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Twirla Main Business Overview
13.2.5 Twirla Latest Developments
13.3 Novartis(HEXAL AG)
13.3.1 Novartis(HEXAL AG) Company Information
13.3.2 Novartis(HEXAL AG) Hormone Patch Product Portfolios and Specifications
13.3.3 Novartis(HEXAL AG) Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis(HEXAL AG) Main Business Overview
13.3.5 Novartis(HEXAL AG) Latest Developments
13.4 Bayer Healthcare Pharmaceuticals
13.4.1 Bayer Healthcare Pharmaceuticals Company Information
13.4.2 Bayer Healthcare Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.4.3 Bayer Healthcare Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Healthcare Pharmaceuticals Main Business Overview
13.4.5 Bayer Healthcare Pharmaceuticals Latest Developments
13.5 Noven
13.5.1 Noven Company Information
13.5.2 Noven Hormone Patch Product Portfolios and Specifications
13.5.3 Noven Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Noven Main Business Overview
13.5.5 Noven Latest Developments
13.6 AbbVie
13.6.1 AbbVie Company Information
13.6.2 AbbVie Hormone Patch Product Portfolios and Specifications
13.6.3 AbbVie Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AbbVie Main Business Overview
13.6.5 AbbVie Latest Developments
13.7 Hisamitsu Pharmaceutical Co., Inc.
13.7.1 Hisamitsu Pharmaceutical Co., Inc. Company Information
13.7.2 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product Portfolios and Specifications
13.7.3 Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hisamitsu Pharmaceutical Co., Inc. Main Business Overview
13.7.5 Hisamitsu Pharmaceutical Co., Inc. Latest Developments
13.8 Watson Pharmaceuticals
13.8.1 Watson Pharmaceuticals Company Information
13.8.2 Watson Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.8.3 Watson Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Watson Pharmaceuticals Main Business Overview
13.8.5 Watson Pharmaceuticals Latest Developments
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Information
13.9.2 Johnson & Johnson Hormone Patch Product Portfolios and Specifications
13.9.3 Johnson & Johnson Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Johnson & Johnson Main Business Overview
13.9.5 Johnson & Johnson Latest Developments
13.10 ANI Pharmaceuticals
13.10.1 ANI Pharmaceuticals Company Information
13.10.2 ANI Pharmaceuticals Hormone Patch Product Portfolios and Specifications
13.10.3 ANI Pharmaceuticals Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 ANI Pharmaceuticals Main Business Overview
13.10.5 ANI Pharmaceuticals Latest Developments
13.11 Zhejiang Yatai Pharmaceutical Company Ltd.
13.11.1 Zhejiang Yatai Pharmaceutical Company Ltd. Company Information
13.11.2 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product Portfolios and Specifications
13.11.3 Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Zhejiang Yatai Pharmaceutical Company Ltd. Main Business Overview
13.11.5 Zhejiang Yatai Pharmaceutical Company Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hormone Patch Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hormone Patch Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Contraceptive Patch
Table 4. Major Players of Estradiol Patch
Table 5. Major Players of Others
Table 6. Global Hormone Patch Sales by Type (2018-2023) & (K Units)
Table 7. Global Hormone Patch Sales Market Share by Type (2018-2023)
Table 8. Global Hormone Patch Revenue by Type (2018-2023) & ($ million)
Table 9. Global Hormone Patch Revenue Market Share by Type (2018-2023)
Table 10. Global Hormone Patch Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Hormone Patch Sales by Application (2018-2023) & (K Units)
Table 12. Global Hormone Patch Sales Market Share by Application (2018-2023)
Table 13. Global Hormone Patch Revenue by Application (2018-2023)
Table 14. Global Hormone Patch Revenue Market Share by Application (2018-2023)
Table 15. Global Hormone Patch Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Hormone Patch Sales by Company (2018-2023) & (K Units)
Table 17. Global Hormone Patch Sales Market Share by Company (2018-2023)
Table 18. Global Hormone Patch Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Hormone Patch Revenue Market Share by Company (2018-2023)
Table 20. Global Hormone Patch Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Hormone Patch Producing Area Distribution and Sales Area
Table 22. Players Hormone Patch Products Offered
Table 23. Hormone Patch Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Hormone Patch Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Hormone Patch Sales Market Share Geographic Region (2018-2023)
Table 28. Global Hormone Patch Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Hormone Patch Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Hormone Patch Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Hormone Patch Sales Market Share by Country/Region (2018-2023)
Table 32. Global Hormone Patch Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Hormone Patch Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Hormone Patch Sales by Country (2018-2023) & (K Units)
Table 35. Americas Hormone Patch Sales Market Share by Country (2018-2023)
Table 36. Americas Hormone Patch Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Hormone Patch Revenue Market Share by Country (2018-2023)
Table 38. Americas Hormone Patch Sales by Type (2018-2023) & (K Units)
Table 39. Americas Hormone Patch Sales by Application (2018-2023) & (K Units)
Table 40. APAC Hormone Patch Sales by Region (2018-2023) & (K Units)
Table 41. APAC Hormone Patch Sales Market Share by Region (2018-2023)
Table 42. APAC Hormone Patch Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Hormone Patch Revenue Market Share by Region (2018-2023)
Table 44. APAC Hormone Patch Sales by Type (2018-2023) & (K Units)
Table 45. APAC Hormone Patch Sales by Application (2018-2023) & (K Units)
Table 46. Europe Hormone Patch Sales by Country (2018-2023) & (K Units)
Table 47. Europe Hormone Patch Sales Market Share by Country (2018-2023)
Table 48. Europe Hormone Patch Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Hormone Patch Revenue Market Share by Country (2018-2023)
Table 50. Europe Hormone Patch Sales by Type (2018-2023) & (K Units)
Table 51. Europe Hormone Patch Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Hormone Patch Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Hormone Patch Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Hormone Patch Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Hormone Patch Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Hormone Patch Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Hormone Patch Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Hormone Patch
Table 59. Key Market Challenges & Risks of Hormone Patch
Table 60. Key Industry Trends of Hormone Patch
Table 61. Hormone Patch Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Hormone Patch Distributors List
Table 64. Hormone Patch Customer List
Table 65. Global Hormone Patch Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Hormone Patch Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Hormone Patch Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Hormone Patch Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Hormone Patch Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Hormone Patch Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Hormone Patch Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Hormone Patch Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Hormone Patch Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Hormone Patch Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Hormone Patch Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Hormone Patch Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Hormone Patch Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Hormone Patch Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Mylan Pharmaceuticals Inc.(Viatris) Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 80. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Product Portfolios and Specifications
Table 81. Mylan Pharmaceuticals Inc.(Viatris) Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Mylan Pharmaceuticals Inc.(Viatris) Main Business
Table 83. Mylan Pharmaceuticals Inc.(Viatris) Latest Developments
Table 84. Twirla Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 85. Twirla Hormone Patch Product Portfolios and Specifications
Table 86. Twirla Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Twirla Main Business
Table 88. Twirla Latest Developments
Table 89. Novartis(HEXAL AG) Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis(HEXAL AG) Hormone Patch Product Portfolios and Specifications
Table 91. Novartis(HEXAL AG) Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Novartis(HEXAL AG) Main Business
Table 93. Novartis(HEXAL AG) Latest Developments
Table 94. Bayer Healthcare Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Healthcare Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 96. Bayer Healthcare Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Bayer Healthcare Pharmaceuticals Main Business
Table 98. Bayer Healthcare Pharmaceuticals Latest Developments
Table 99. Noven Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 100. Noven Hormone Patch Product Portfolios and Specifications
Table 101. Noven Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Noven Main Business
Table 103. Noven Latest Developments
Table 104. AbbVie Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 105. AbbVie Hormone Patch Product Portfolios and Specifications
Table 106. AbbVie Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. AbbVie Main Business
Table 108. AbbVie Latest Developments
Table 109. Hisamitsu Pharmaceutical Co., Inc. Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 110. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Product Portfolios and Specifications
Table 111. Hisamitsu Pharmaceutical Co., Inc. Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Hisamitsu Pharmaceutical Co., Inc. Main Business
Table 113. Hisamitsu Pharmaceutical Co., Inc. Latest Developments
Table 114. Watson Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 115. Watson Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 116. Watson Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Watson Pharmaceuticals Main Business
Table 118. Watson Pharmaceuticals Latest Developments
Table 119. Johnson & Johnson Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 120. Johnson & Johnson Hormone Patch Product Portfolios and Specifications
Table 121. Johnson & Johnson Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Johnson & Johnson Main Business
Table 123. Johnson & Johnson Latest Developments
Table 124. ANI Pharmaceuticals Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 125. ANI Pharmaceuticals Hormone Patch Product Portfolios and Specifications
Table 126. ANI Pharmaceuticals Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. ANI Pharmaceuticals Main Business
Table 128. ANI Pharmaceuticals Latest Developments
Table 129. Zhejiang Yatai Pharmaceutical Company Ltd. Basic Information, Hormone Patch Manufacturing Base, Sales Area and Its Competitors
Table 130. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Product Portfolios and Specifications
Table 131. Zhejiang Yatai Pharmaceutical Company Ltd. Hormone Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Zhejiang Yatai Pharmaceutical Company Ltd. Main Business
Table 133. Zhejiang Yatai Pharmaceutical Company Ltd. Latest Developments
List of Figures
Figure 1. Picture of Hormone Patch
Figure 2. Hormone Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hormone Patch Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hormone Patch Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hormone Patch Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Contraceptive Patch
Figure 10. Product Picture of Estradiol Patch
Figure 11. Product Picture of Others
Figure 12. Global Hormone Patch Sales Market Share by Type in 2022
Figure 13. Global Hormone Patch Revenue Market Share by Type (2018-2023)
Figure 14. Hormone Patch Consumed in Hospital
Figure 15. Global Hormone Patch Market: Hospital (2018-2023) & (K Units)
Figure 16. Hormone Patch Consumed in Clinic
Figure 17. Global Hormone Patch Market: Clinic (2018-2023) & (K Units)
Figure 18. Global Hormone Patch Sales Market Share by Application (2022)
Figure 19. Global Hormone Patch Revenue Market Share by Application in 2022
Figure 20. Hormone Patch Sales Market by Company in 2022 (K Units)
Figure 21. Global Hormone Patch Sales Market Share by Company in 2022
Figure 22. Hormone Patch Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Hormone Patch Revenue Market Share by Company in 2022
Figure 24. Global Hormone Patch Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Hormone Patch Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Hormone Patch Sales 2018-2023 (K Units)
Figure 27. Americas Hormone Patch Revenue 2018-2023 ($ Millions)
Figure 28. APAC Hormone Patch Sales 2018-2023 (K Units)
Figure 29. APAC Hormone Patch Revenue 2018-2023 ($ Millions)
Figure 30. Europe Hormone Patch Sales 2018-2023 (K Units)
Figure 31. Europe Hormone Patch Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Hormone Patch Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Hormone Patch Revenue 2018-2023 ($ Millions)
Figure 34. Americas Hormone Patch Sales Market Share by Country in 2022
Figure 35. Americas Hormone Patch Revenue Market Share by Country in 2022
Figure 36. Americas Hormone Patch Sales Market Share by Type (2018-2023)
Figure 37. Americas Hormone Patch Sales Market Share by Application (2018-2023)
Figure 38. United States Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Hormone Patch Sales Market Share by Region in 2022
Figure 43. APAC Hormone Patch Revenue Market Share by Regions in 2022
Figure 44. APAC Hormone Patch Sales Market Share by Type (2018-2023)
Figure 45. APAC Hormone Patch Sales Market Share by Application (2018-2023)
Figure 46. China Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Hormone Patch Sales Market Share by Country in 2022
Figure 54. Europe Hormone Patch Revenue Market Share by Country in 2022
Figure 55. Europe Hormone Patch Sales Market Share by Type (2018-2023)
Figure 56. Europe Hormone Patch Sales Market Share by Application (2018-2023)
Figure 57. Germany Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Hormone Patch Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Hormone Patch Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Hormone Patch Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Hormone Patch Sales Market Share by Application (2018-2023)
Figure 66. Egypt Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Hormone Patch Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Hormone Patch in 2022
Figure 72. Manufacturing Process Analysis of Hormone Patch
Figure 73. Industry Chain Structure of Hormone Patch
Figure 74. Channels of Distribution
Figure 75. Global Hormone Patch Sales Market Forecast by Region (2024-2029)
Figure 76. Global Hormone Patch Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Hormone Patch Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Hormone Patch Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Hormone Patch Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Hormone Patch Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ホルモンパッチのグローバル市場予測2023-2029(Global Hormone Patch Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆